Live tape
Top 8, mentions 7d10,784GOOGL2,064 mentions▲ +0.04SNDK1,523 mentions▲ +0.11SPCX1,495 mentions▲ +0.08NBIS1,421 mentions▲ +0.09HTZ1,232 mentions▲ +0.10NVDA1,190 mentions▲ +0.08META1,018 mentions▲ +0.03MSFT841 mentions▲ +0.06

Equity · Healthcare

SMMT

Summit Therapeutics Inc. · NasdaqGM

$13.54 −1.74% 1D Finazon · prior-day close · Aug 5, 2026
Price · Chart
Our own end-of-day closes 53 sessions
$20 $12 20 May 5 Aug

The line runs $17.90 on 20 May through $13.54 on 5 August, on a scale from $12 to $20. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of SMMT over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 53 sessions over that window: $17.90 on 20 May 2026 through $13.54 on 5 August 2026.

Market cap $10.8B
52-week range $12.55 – $29
Avg volume 1.1M

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

SMMT insider trades

SEC Form 4 · last 90 days · newest reported trade 12 Jun 2026
Open-market buys 5
Open-market sells 0
Net bought $103.26M
Non-trade filings 0
Date Insider Type Shares Value
12 Jun 2026 DUGGAN ROBERT W Co-Chief Executive Officer Buy 3,810,000 $49.99M
12 Jun 2026 Zanganeh Mahkam Co-Chief Executive Officer Buy 3,810,000 $49.99M
04 Jun 2026 DUGGAN ROBERT W Co-Chief Executive Officer Buy 100,000 $1.46M
04 Jun 2026 Soni Manmeet Singh COO and CFO Buy 25,000 $362K
04 Jun 2026 Zanganeh Mahkam Co-Chief Executive Officer Buy 100,000 $1.46M

SMMT reported financials

SEC EDGAR XBRL

SMMT reported net income of −$1.1B for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$1.1B 31 Dec 2025 fiscal year
Diluted EPS −$1.44 31 Dec 2025 fiscal year
Total assets $752.2M 30 Jun 2026 at period end
Total equity $630.0M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

SMMT earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.28 —
31 Mar 2026 Q1 2026 $-0.24 —
31 Dec 2025 FY 2025 $-1.44 —
30 Sep 2025 Q3 2025 $-0.31 —
30 Jun 2025 Q2 2025 $-0.76 —
31 Mar 2025 Q1 2025 $-0.09 —
31 Dec 2024 FY 2024 $-0.31 —
30 Sep 2024 Q3 2024 $-0.08 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

SMMT institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a SMMT position for the quarter ended 30 Jun 2026 — a combined $663.3M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) −9.9% shares 32,786,348 $477.7M
Point72 Asset Management Added +371.5% shares 3,697,803 $53.9M
Millennium Management Added +1,760.3% shares 2,349,081 $34.2M
Balyasny Asset Management Added +247.3% shares 1,904,254 $27.7M
Citadel Advisors Added +290.7% shares 1,725,716 $25.1M
D. E. Shaw & Co. Trimmed −44.5% shares 1,243,556 $18.1M
Two Sigma Investments Trimmed −29.0% shares 696,714 $10.2M
Marshall Wace Held (±25%) +21.5% shares 577,190 $8.4M
AQR Capital Management Held (±25%) +22.2% shares 542,178 $7.9M
Tudor Investment Corp Exited

Source: SEC EDGAR 13F filings

SMMT fails-to-deliver

SEC CNS data

On 24 Jul 2026, 54 shares of SMMT failed to deliver (about $809) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
24 Jul 2026 54 $809 <0.001%
23 Jul 2026 10 $147 <0.001%
21 Jul 2026 1,074 $14K <0.001%
17 Jul 2026 1,087 $15K <0.001%
06 Jul 2026 8,095 $125K 0.001%

Source: SEC fails-to-deliver (CNS) data